Therapeutics Supplements and Botanicals

Ganoderma lucidum and Hypericum perforatum Exhibit Anti-Inflammatory, Antioxidant, and Anti-Androgen Effect in Rat Model of Experimental Polycystic Ovarian Syndrome

Okay G, Kırıcı P, Mavral N, Utkan Korun ZE, Annac E, Kaplan S

Medical Principles and Practice, 2024
DOI 10.1159/000538595 PMID 38599178 PMC PMC11324204

RRM Academy Synopsis

Reishi extract and Saint John's wort reduced PCOS-like signs in rats

Reishi extract and Saint John's wort reduced cystic follicles in PCOS-model rats, an animal study of 42 female rats found. Both herbs also lowered testosterone in the PCOS-model rats by about half. In those rats, each herb lowered MDA, a sign of oxidative stress, and raised the antioxidant glutathione. PCOS is also called PMOS (Polyendocrine Metabolic Ovarian Syndrome).

Key Findings

  • Untreated PCOS-model rats averaged 9.28 cystic follicles, against 2.14 with reishi extract, 1.57 with Saint John's wort and 1.28 in controls (PCOS group against all others, p < 0.05).
  • Follicle degeneration averaged 2.28 in untreated PCOS-model rats and 0.71 in each herb-treated PCOS group (p < 0.05), on a 0 to 3 scale where 3 means over 66% damage.
  • Testosterone was higher in PCOS-model rats, and adding either herb lowered it by about half. SHBG, a protein that carries sex hormones in the blood, was lower and rose with both herbs.
  • MDA, a marker of oxidative stress, fell with either herb (p < 0.05). Glutathione, an antioxidant that was low in PCOS-model rats, rose with either herb (p < 0.05).
  • TNF-alpha, an inflammation marker, fell with either herb, and IGF-1 fell with reishi extract only. LH, FSH and insulin were similar across all six groups.

Interpretation

Researchers gave female rats a drug to mimic PCOS, a common laboratory model, and later checked their ovaries and blood. The six groups of seven rats included healthy controls, untreated and treated PCOS-model rats, and rats given an herb alone. The reishi product was a polysaccharide extract of the mushroom Ganoderma lucidum, and Saint John's wort is the plant Hypericum perforatum. The authors note that human studies would be far more valuable, and they call for randomized trials of both herbs in people.

RRM Context

RRM approaches PCOS as a condition with underlying causes to find and treat, with the goal of restoring healthy ovulation. The authors see chronic, low-grade inflammation as a likely part of how PCOS develops, though its exact role isn't yet clear. The experiment measured inflammation and oxidative stress directly. That focus on biological causes fits the RRM view of the condition.

Abstract

Objective

Chronic inflammation is considered to be of key importance in the pathogenesis of polycystic ovarian syndrome (PCOS). Ganoderma lucidum polysaccharide (GLP) and Hypericum perforatum (HP) have been reported to have anti-inflammatory and antioxidant activities. We studied the effects of these agents on ovarian tissue in a rat model of experimental PCOS.

Materials and Methods

Forty-two Sprague-Dawley female rats were divided into 6 groups with 7 animals in each group as listed below: Group 1: Control, Group 2: PCOS, Group 3: PCOS + HP, Group 4: HP only, Group 5: PCOS+ GLP, Group 6: GLP only. At the end of the experimental procedures, all the animals underwent bilateral oophorectomy and blood samples were collected. Ovarian tissue and blood samples were used for biochemical and histopathological analysis.

Results

Follicle degeneration in the PCOS group showed a statistically significant increase compared to the other groups (p < 0.05). Cystic follicles were significantly reduced in the PCOS+GLP and PCOS+HP groups as compared to the PCOS group. Levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) were elevated in PCOS rats (p < 0.01). Levels of sex hormone binding globulin (SHBG) levels were diminished (p < 0.01). Levels of malondialdehyde (MDA) and insulin-like growth factor 1 (IGF-1) were increased in PCOS rats as compared to the other groups (p < 0.02, p < 0.02, respectively). GLP supplementation diminished the levels of IGF-1 and MDA. GLP or HP supplementation increased reduced glutathione (GSH).

Conclusion

GLP and HP treatment normalizes SHBG levels while correcting PCOS-induced hyperandrogenemia. Both herbs regulate the redox balance by decreasing the levels of MDA and increasing the level of GSH.

Topics

Related research

Therapeutics › Supplements and Botanicals › Herbal and Botanical Products · Reproductive Endocrinology › Ovarian Hormones › Androgens · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances
Gülin Okay, Pınar Kırıcı, Nihal Mavral, Zeynep Ece Utkan Korun, Ebru Annac, Selçuk Kaplan
G Okay, P Kırıcı, N Mavral, Z Korun, E Annac, S Kaplan
PMID 38599178 38599178 DOI 10.1159/000538595 10.1159/000538595 Okay et al. 2024, Okay 2024